by James Rudge, PhD, Technical Director, Neoteryx | 8 min read
An article published by Nils T. Vethe et al in the October 2019 issue of Therapeutic Drug Monitoring, reported on the successful validation of 10 µL Mitra® devices from 26-27 …
Read Storyby Neoteryx | 3 min read
The COVID-19 pandemic has created a shift in the way researchers collect specimen samples for scientific studies and clinical trials. The scientific community has found it increasingly difficult to recruit …
Read Storyby Neoteryx | 3 min read
A viral pandemic was something that scientists had long predicted, but when and how it would strike was not known. Scientists and researchers also did not know that it would …
Read Storyby Neoteryx | 5 min read
According to a 2014 study, the cost of developing a new drug is $2.6 billion. This high expense doesn’t include the additional cost of post-approval development to determine dosage strengths …
Read Story